Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

JHEP Reports(2024)10.1016/j.jhepr.2024.101295Source: DataRank Database

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab is a research paper published in JHEP Reports (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab · RWTH Aachen University

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.63)OA: goldTopics (34)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (59)

Philipp Mildenberger ORCID,Jennifer Gile ORCID,Fabian Jost‐Brinkmann ORCID,Bernhard Scheiner ORCID,Catherine Leyh

Live enrichment

PubMed:40059970 PMC:PMC11889551 OpenAlex:https://openalex.org/W4405045987

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5K23MD017217-04

Working to Eliminate Care Disparities in Liver Cancer in Southeast Asian Americans: Transportation and Other Social Determinants of Health.

National Institutes of Health

Grant: 9R01EB001981-06

Magnetic Resonance Elastography

FWCI

2.63

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.jhep-reports.eu/article/S2589-5559(24)00299-4/pdf

publisherhttps://www.jhep-reports.eu/article/S2589-5559(24)00299-4/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2589555924002994?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2589555924002994?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jhepr.2024.101295

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisMedicine03 medical and health sciences0302 clinical medicine

Keywords

AtezolizumabBevacizumabMedicineOncologyInternal medicineImmunotherapyCancerNivolumabChemotherapyDevelopmentCirrhosisHepatocellular carcinomaValidationPrediction modelVEGFPD-L1OutcomeSystemic TherapyImmune Checkpoint InhibitorsCable ScoreMedizin610 Medizin610RC799-869Diseases of the digestive system. Gastroenterology610 Medical sciencesinfo:eu-repo/classification/ddc/610Research Article

Sustainable Development Goals

SDG 0: Good health and well-being

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

10.18154/rwth-2026-02955RWTH Aachen University

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

FAIR Checklist

Authors (59)

Funding (3 grants)

Impact

Open Access

Topics

Linked Datasets (1)

Annotations (Europe PMC)